Quixant PLC
LSE:QXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Quixant PLC
LSE:QXT
|
UK |
|
Voltalia SA
PAR:VLTSA
|
FR |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
C
|
China Reinsurance Group Corp
HKEX:1508
|
CN |
|
Luminar Technologies Inc
NASDAQ:LAZR
|
US |
|
Leggett & Platt Inc
NYSE:LEG
|
US |
|
Territorial'naya Generiruyushchaya Kompaniya No2 PAO
MOEX:TGKB
|
RU |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
IL |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
Oracle Corp Japan
TSE:4716
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is QXT's stock price target?
Not Available
QXT doesn't have any price targets made by Wall Street professionals.
What is Quixant PLC's Revenue forecast?
Projected CAGR
-5%
For the last 8 years the
compound annual growth rate for
Quixant PLC's revenue is
18%.
The projected
CAGR
for the next 2 years is
-5%.
What is Quixant PLC's Net Income forecast?
Projected CAGR
-11%
For the last 8 years the
compound annual growth rate for
Quixant PLC's net income is
8%.
The projected
CAGR
for the next 2 years is
-11%.